ArticleBiomedicines2025

Preclinical Safety Profile of Deg-AZM, a Clinical-Stage New Transgelin Agonist: hERG Inhibition Study In Vitro, Cardiovascular-Respiratory Pharmacology, and Single/Repeated-Dose Toxicity in Beagle Dogs.

Xiaoting Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.